Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccines

Set Alert for Vaccines

Verovaccines gets larger research facility as company goes standalone

German start-up Verovaccines will further develop its pipeline at a new R&D facility in Halle.

Operations R&D

Animal Pharm seeks freelance special reports writers

Animal Pharm is looking for new authors for its animal health industry reports team.

Policy & Regulation Companion Animals

Intervacc bags Horizon 2020 funding for pig vaccine

Swedish firm Intervacc has received funding from the Eurostars-2 program to aid development of a vaccine against Streptococcus suis in pigs.

Investments R&D

US swine association calls for funding of FMD vaccine bank

The National Pork Producers Council (NPPC) has called for funding for a foot-and-mouth disease (FMD) vaccine bank in the next Farm Bill.

R&D Vaccines

Boehringer to make record €200m investment in France's vaccine valley

Boehringer Ingelheim has continued to develop its network of vaccine capabilities by spending over €200 million ($235 million) to establish a new vaccine production center in France.

Boehringer Ingelheim Animal Health Vaccines

Phibro to establish first vaccine manufacturing plant in Europe

Phibro Animal Health plans to establish a new vaccine production facility in Sligo, Ireland.

Phibro Animal Health Ireland

Finnish center gets positive trial results for PWD vaccine

VTT Technical Research Centre of Finland has gained promising results from the first trials of a vaccine against post-weaning diarrhea (PWD) in pigs.

R&D Porcine

Pirbright develops new combination poultry vaccine

Researchers at the UK's Pirbright Institute claim to have developed a recombinant vaccine effective against both Marek's disease (MD) and infectious bursal disease (IBD) using a new viral vector.

Vaccines Poultry

Zoetis sets up virtual hub to counter outbreaks of infectious diseases

Zoetis aims to improve reactions to new outbreaks through the establishment of the Center for Transboundary and Emerging Diseases.

Zoetis Operations

Hipra mastitis vaccine gets European extension

Hipra has extended the European availability of its Vimco vaccine for the prevention of mastitis in sheep and goats.

Netherlands United Kingdom

Zoetis launches PCV2 vaccine in EU

Zoetis has launched its Suvaxyn Circo vaccine against porcine circovirus type 2 (PCV2) in Europe.

Zoetis Vaccines

Zoetis, Boehringer and Ceva secure Canadian approval for biologicals

Leading veterinary vaccine developers Zoetis, Boehringer Ingelheim Animal Health and Ceva Santé Animale have extended their portfolios in Canada.

Canada Vaccines
See All
Advertisement
UsernamePublicRestriction

Register